TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
RLAY

Relay Therapeutics Inc

Healthcare · Biotechnology

18.20$ -3.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RLAY
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
98.9% 91.7% 96.3% 96.8% 92.7% 91.2% 92.9% 93.1%
98.3% 10.7% 56.0% 27.8% 13.8% 17.0% 14.3% 13.5%
98.3% 90.5% 84.8% 95.0% 90.8% 88.9% 89.7% 89.2%
10.3% 0.5% 0.5% 0.0%
-29.8% -67.7% 1.1%
0.8% 8.1% 3.6% 0.6% 1.1%
0.2% 0.2% 0.3% 0.3%
125.9% 145.9% 4.6% 11.0% 13.6% 10.9% 10.7% 8.7%
1.6% 3.0% 1.7% 2.4% 5.8% 3.6% 5.8% 4.1%
0.0% 0.3% 0.2% 0.2% 0.4% 0.6% 0.7% 0.6%
1.1% 1.8% 0.8% 0.8% 1.0% 1.1% 1.6% 1.2%
-25.9% -45.9% 95.4% 89.0% 86.4% 89.1% 89.3% 91.3%
-26.6% -48.2% -50.5% -76.2% -96.3% -165.9% -199.5% -324.3%
0.6% 1.1% 11.3% 9.4% 10.2% 14.5% 16.4% 27.6%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?